Inflammatix, Inc.

Inflammatix, Inc. company information, Employees & Contact Information

Inflammatix, Inc., based in Sunnyvale, California, USA, is revolutionizing molecular diagnostics with machine-learning-powered technology to rapidly read a patient’s immune response to improve patient care and reduce major public health burdens. It’s flagship in vitro diagnostic (IVD) test, the TriVerity™ Test System (“TriVerity”) shows the likelihood of a bacterial infection, a viral infection, and illness severity in adult patients with suspected acute infection or sepsis that present to emergency departments. TriVerity empowers physicians to confidently make care decisions, which could influence the selection of antimicrobial therapy, focused workups with judicious laboratory and imaging orders, and patient admission or discharge disposition. TriVerity and future tests are designed to be performed on the company’s proprietary Myrna™ instrument, a cartridge-based benchtop analyzer that is capable of multiplex sample-to-answer quantitation of mRNA in about 30 minutes.

Company Details

Employees
91
Founded
-
Address
540 Oakmead Pkwy, Sunnyvale,california 94085,united States
Phone
650-443-3030
Email
in****@****tix.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Sunnyvale, California
Looking for a particular Inflammatix, Inc. employee's phone or email?

Inflammatix, Inc. Questions

News

Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System - PR Newswire

Inflammatix Data in Journal of Clinical Microbiology Validate Accuracy, Robustness, and Ease of Use of TriVerity™ Test System PR Newswire

Inflammatix's TriVerity™ Test Secures NTAP Reimbursement from CMS for First-in-Class Severity Score Working in Concert with Bacterial and Viral Insights - PR Newswire

Inflammatix's TriVerity™ Test Secures NTAP Reimbursement from CMS for First-in-Class Severity Score Working in Concert with Bacterial and Viral Insights PR Newswire

Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test - PR Newswire

Inflammatix Receives FDA Clearance for First-in-Class TriVerity™ Test PR Newswire

Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis - Nature

Clinical validation of an AI-based blood testing device for diagnosis and prognosis of acute infection and sepsis Nature

Revolutionizing sepsis diagnostics with new breakthrough technology - SelectScience

Revolutionizing sepsis diagnostics with new breakthrough technology SelectScience

Inflammatix raises $57M to advance test for infection, sepsis - MedTech Dive

Inflammatix raises $57M to advance test for infection, sepsis MedTech Dive

Inflammatix Scores FDA Approval for Precision Infection Test - Inside Precision Medicine

Inflammatix Scores FDA Approval for Precision Infection Test Inside Precision Medicine

Inflammatix collects FDA clearance for ER sepsis diagnostic test - Fierce Biotech

Inflammatix collects FDA clearance for ER sepsis diagnostic test Fierce Biotech

Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military - PR Newswire

Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military PR Newswire

Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial - PR Newswire

Inflammatix Initiates TriVerity™ for Improved Management of Emergency Department Patients with Suspected Infections (TIMED) Trial PR Newswire

Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment - PR Newswire

Inflammatix Announces Three Landmark Publications in Nature Medicine that Redefine Acute Infection and Sepsis Diagnosis and Treatment PR Newswire

Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis - PR Newswire

Inflammatix Secures $57 Million to Advance Novel Diagnostic for Patients with Suspected Infections or Sepsis PR Newswire

Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerity™ Test System - PR Newswire

Inflammatix Names Martín Vazquez as Chief Operating Officer to Drive National Scale-Up of TriVerity™ Test System PR Newswire

Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System - PR Newswire

Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity™ Acute Infection and Sepsis Test System PR Newswire

Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team - PR Newswire

Inflammatix Adds Three MedTech Industry Veterans to Executive Leadership Team PR Newswire

Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System - PR Newswire

Inflammatix Completes Technical Development for TriVerity™ Acute Infection and Sepsis Test System PR Newswire

Inflammatix Announces $32 Million in Series C Funding - PR Newswire

Inflammatix Announces $32 Million in Series C Funding PR Newswire

New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System - PR Newswire

New Inflammatix Study in Nature Communications Outlines Breakthrough in Diagnosing Acute Infections by Reading the Immune System PR Newswire

Inflammatix Announces Funding from BARDA to Advance HostDx™ Tests - PR Newswire

Inflammatix Announces Funding from BARDA to Advance HostDx™ Tests PR Newswire

Inflammatix Wins AACC's Disruptive Technology Award For Its Rapid HostDx™ Tests - PR Newswire

Inflammatix Wins AACC's Disruptive Technology Award For Its Rapid HostDx™ Tests PR Newswire

Prospective validation of an 11-gene mRNA host response score for mortality risk stratification in the intensive care unit - Nature

Prospective validation of an 11-gene mRNA host response score for mortality risk stratification in the intensive care unit Nature

Inflammatix’s Triverity scores FDA clearance for ER sepsis test - BioWorld MedTech

Inflammatix’s Triverity scores FDA clearance for ER sepsis test BioWorld MedTech

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member - Business Wire

Inflammatix Appoints Dr. Kian Beyzavi as New Board Member Business Wire

Inflammatix nets $102M to advance its immune system tests for infectious diseases - Fierce Biotech

Inflammatix nets $102M to advance its immune system tests for infectious diseases Fierce Biotech

BARDA backs Inflammatix test to improve antibiotic use - MedTech Dive

BARDA backs Inflammatix test to improve antibiotic use MedTech Dive

Top Inflammatix, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant